Fremman Capital acquires Portobello Capital’s stake in AGQ Labs, a leading global testing and analysis laboratory platform, and partners with the founders to support the company’s next stage of growth
Fremman Capital acquires a majority stake in Italian specialty In Vitro Diagnostics (IVD) leader DIESSE Diagnostica Senese in a bilateral transaction with private equity healthcare specialist ARCHIMED
Fremman Capital enters into a put option agreement to acquire Innovative Beauty Group, a pioneering turn-key solution provider servicing retailers and brands in the Beauty and Personal Care space
